Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 797.00
-5.75 (-0.72%)
Jul 31, 2026, 3:29 PM IST
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 156.67 billion as of July 31, 2026. Its market cap has decreased by -20.90% in one year.
Market Cap
156.67B
Enterprise Value
168.95B
Revenue
73.45B
Ranking
n/a
PE Ratio
23.22
Stock Price
797.00
ChartMarket Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 156.67B, an increase of 1,640.47%. That is a compound annual growth rate of 21.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 156.67B | -5.80% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 360.92B |
| Wockhardt | 311.42B |
| Piramal Pharma | 259.70B |
| Eris Lifesciences | 197.67B |
| NATCO Pharma | 167.64B |
| Cohance Lifesciences | 165.00B |
| Alivus Life Sciences | 137.42B |
| Akums Drugs and Pharmaceuticals | 101.74B |